Market Research Logo

Endocyte, Inc. - Product Pipeline Review - 2015

Endocyte, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Endocyte, Inc. - Product Pipeline Review - 2015’, provides an overview of the Endocyte, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Endocyte, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Endocyte, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Endocyte, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Endocyte, Inc.’s pipeline products
Reasons to buy
  • Evaluate Endocyte, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Endocyte, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Endocyte, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Endocyte, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Endocyte, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Endocyte, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Endocyte, Inc. Snapshot
Endocyte, Inc. Overview
Key Information
Key Facts
Endocyte, Inc. - Research and Development Overview
Key Therapeutic Areas
Endocyte, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Endocyte, Inc. - Pipeline Products Glance
Endocyte, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Endocyte, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Endocyte, Inc. - Drug Profiles
vintafolide
Product Description
Mechanism of Action
R&D Progress
EC-1169
Product Description
Mechanism of Action
R&D Progress
EC-1456
Product Description
Mechanism of Action
R&D Progress
EC-0371
Product Description
Mechanism of Action
R&D Progress
EC-0531
Product Description
Mechanism of Action
R&D Progress
EC-1069
Product Description
Mechanism of Action
R&D Progress
EC-1496
Product Description
Mechanism of Action
R&D Progress
EC-1669
Product Description
Mechanism of Action
R&D Progress
EC-1744
Product Description
Mechanism of Action
R&D Progress
EC-1788
Product Description
Mechanism of Action
R&D Progress
EC-1953
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Target Folate Receptor Beta for Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Target Folate Receptors for Cancer
Product Description
Mechanism of Action
R&D Progress
Endocyte, Inc. - Pipeline Analysis
Endocyte, Inc. - Pipeline Products by Target
Endocyte, Inc. - Pipeline Products by Route of Administration
Endocyte, Inc. - Pipeline Products by Molecule Type
Endocyte, Inc. - Pipeline Products by Mechanism of Action
Endocyte, Inc. - Recent Pipeline Updates
Endocyte, Inc. - Dormant Projects
Endocyte, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
vintafolide
Endocyte, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Endocyte, Inc., Key Information
Endocyte, Inc., Key Facts
Endocyte, Inc. - Pipeline by Indication, 2015
Endocyte, Inc. - Pipeline by Stage of Development, 2015
Endocyte, Inc. - Monotherapy Products in Pipeline, 2015
Endocyte, Inc. - Phase II, 2015
Endocyte, Inc. - Phase I, 2015
Endocyte, Inc. - Preclinical, 2015
Endocyte, Inc. - Discovery, 2015
Endocyte, Inc. - Pipeline by Target, 2015
Endocyte, Inc. - Pipeline by Route of Administration, 2015
Endocyte, Inc. - Pipeline by Molecule Type, 2015
Endocyte, Inc. - Pipeline Products by Mechanism of Action, 2015
Endocyte, Inc. - Recent Pipeline Updates, 2015
Endocyte, Inc. - Dormant Developmental Projects,2015
Endocyte, Inc. - Discontinued Pipeline Products, 2015
Endocyte, Inc., Other Locations
List of Figures
Endocyte, Inc. - Pipeline by Top 10 Indication, 2015
Endocyte, Inc. - Pipeline by Stage of Development, 2015
Endocyte, Inc. - Monotherapy Products in Pipeline, 2015
Endocyte, Inc. - Pipeline by Top 10 Target, 2015
Endocyte, Inc. - Pipeline by Top 10 Route of Administration, 2015
Endocyte, Inc. - Pipeline by Top 10 Molecule Type, 2015
Endocyte, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report